Characterization of B cell and antibody responses induced by vaccination against the human coronaviruses MERS-CoV and SARS-CoV-2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Hamburg, Universität Hamburg, Dissertation, 2023
- Schlagwort
-
Impfstoff
Virusinfektion
Impfstoff
B-Lymphozyt
Antikörper
Coronaviren
SARS-CoV-2
Humorale Immunität
- Ereignis
-
Veröffentlichung
- (wo)
-
Hamburg
- (wer)
-
Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
- (wann)
-
2023
- Urheber
-
Weskamm, Leonie Marie
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:gbv:18-ediss-110424
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weskamm, Leonie Marie
- Addo, Marylyn M.
- Dobner, Thomas
- Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
Entstanden
- 2023
Ähnliche Objekte (12)
Spike-specific T cell immunity following vaccination against the human coronaviruses SARS-CoV-2 and MERS-CoV
Vaccination against SARS-CoV-2: a human enhancement story
Proteomic landscape of SARS-CoV-2 and MERS-CoVinfected primary human renal epithelial cells
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Vaccination and Antibody Testing in Cats
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
Development of a novel SARS-CoV-2 vaccination strategy with a monomeric Spike Designer Antigen to prime efficient antibody responses in aged mice
Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Spike-specific T cell immunity following vaccination against the human coronaviruses SARS-CoV-2 and MERS-CoV
Vaccination against SARS-CoV-2: a human enhancement story
Proteomic landscape of SARS-CoV-2 and MERS-CoVinfected primary human renal epithelial cells
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Vaccination and Antibody Testing in Cats
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
Development of a novel SARS-CoV-2 vaccination strategy with a monomeric Spike Designer Antigen to prime efficient antibody responses in aged mice
Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Spike-specific T cell immunity following vaccination against the human coronaviruses SARS-CoV-2 and MERS-CoV
Vaccination against SARS-CoV-2: a human enhancement story
Proteomic landscape of SARS-CoV-2 and MERS-CoVinfected primary human renal epithelial cells
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Vaccination and Antibody Testing in Cats
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
Development of a novel SARS-CoV-2 vaccination strategy with a monomeric Spike Designer Antigen to prime efficient antibody responses in aged mice
Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination